Biovaxys Technology Corp
OTC:BVAXF
Relative Value
There is not enough data to reliably calculate the relative value of BVAXF.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BVAXF Competitors Multiples
Biovaxys Technology Corp Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
B
|
Biovaxys Technology Corp
OTC:BVAXF
|
3.3m USD | 0 | -0.5 | -0.7 | -0.7 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
223.7B USD | 0 | 0 | 0 | 0 | |
| UK |
E
|
Eight Capital Partners PLC
F:ECS
|
158.4B EUR | 0 | 0 | 0 | 0 | |
| US |
C
|
China Industrial Group Inc
OTC:CIND
|
121B USD | 351.6 | 4 020.7 | 3 417.4 | 3 537.2 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
108.7B ZAR | 6.4 | 10.1 | 15.8 | 15.9 | |
| CH |
G
|
Galderma Group AG
SIX:GALD
|
35.4B CHF | 0 | 0 | 0 | 0 | |
| US |
C
|
CoreWeave Inc
NASDAQ:CRWV
|
44.6B USD | 0 | 0 | 0 | 0 | |
| US |
I
|
Inspire Veterinary Partners Inc
NASDAQ:IVP
|
44.2B USD | 1 936.3 | -2 522.7 | -5 712.8 | -4 926.5 | |
| US |
|
Coupang Inc
F:788
|
29.2B EUR | 1 | 88.2 | 22.8 | 37.6 | |
| ID |
|
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
559.4T IDR | 46.7 | -129 | 2 733.4 | 2 733.4 | |
| ZA |
F
|
Fortress Real Estate Investments Ltd
JSE:FFB
|
32B ZAR | 5.3 | 12 | 13.3 | 13.3 |